Inventor

James A. Audia

Inventor

Indianapolis, IN, US

Overview

2003–2008

Patent span

Human necessities

Primary field (CPC A)

Patents· 12 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes26%

C07DHeterocyclic compounds26%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%

C07CAcyclic or carbocyclic compounds24%

PatentTitleYear

7,390,801'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2008 7,153,847'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2006 6,951,854'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Î²-amyloid peptide release and/or its synthesis by use of such compounds'2005 6,683,075'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use'2004 6,667,305'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,653,303'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,635,632'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,632,811'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,579,867'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,559,141'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,544,978'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003 6,541,466'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2008Patents assigned to LILLY CO ELI (12)· patent assignee history

2003–2008Patents assigned to ATHENA NEUROSCIENCES INC (10)· patent assignee history

2003–2008Based in Indianapolis, IN, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
LILLY CO ELI	12	2003–2008
ATHENA NEUROSCIENCES INC	10	2003–2008

Locations

Location	Patents	Span
Indianapolis, IN, US	12	2003–2008